# FDA Inspection 1288954 - SOFIE Co. dba SOFIE - October 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/f23fa115-173f-44cf-b3a9-5ba539fae69c
Source feed: FDA_Inspections

> FDA Inspection 1288954 for SOFIE Co. dba SOFIE on October 28, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1288954
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2025-10-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 999635 - 2017-01-04](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/88b5b8b4-7f3f-4a02-8129-d6f64ab3f0b1)
- [FDA Inspection 977923 - 2016-05-06](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/77065922-68ba-4a57-b666-95100d728567)
- [FDA Inspection 800995 - 2012-09-27](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/d3df9b7b-914c-40f2-bd3c-1c13721d65a1)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/2788a42c-0f99-4a95-8de3-ef2e88c93110

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9